Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy

FDA inspection history in Bristol, Tennessee, 2019 to 2020

1
Close-out
1
Form 483

Every document, by year

  • Close-out
  • Form 483

2019: one Form 483; 2020: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019–20One Form 483 and one close-out letter, at Bristol, Tennessee.

Cited most

Across all Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy observations on file

  • FDCA 501(a)(2)(A)
    Insanitary conditions
    4

The complete Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2020-01-13Close-out Close-out letter$99
2019-04-05483 Form 483$99

Investigators on these documents

June P. Page (1)Xiaohui Shen (1)

FEI number 3014877770 · most recent document Jan 13, 2020

About Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy

How many FDA Form 483s has Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy received?

FDA Intel has 1 Form 483 on file for Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy; the most recent is dated Apr 5, 2019.

When was Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy is a Form 483 dated Apr 5, 2019, for the site in Bristol, Tennessee.

What did FDA cite at Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy?

The regulations cited most in the observations on file for Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy are FDCA 501(a)(2)(A) (Insanitary conditions), 4 times.